Erratum: Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation (Journal of Clinical Investigation (2012) 122, 6 (2130-2140) DOI:10.1172/JCI60006);Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation

Journal of Clinical Investigation

Volumn 122, Issue 6, 2012, Pages 2130-2140

  Vandevyver, Sofie ^a,b   Dejager, Lien ^a,b   Van Bogaert, Tom ^a,b   Kleyman, Anna ^c   Liu, Yusen ^d   Tuckermann, Jan ^e   Libert, Claude ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c FRITZ LIPMANN INSTITUTE   (Germany)

^d THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; RECOMBINANT TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DIMERIZATION; ENTERITIS; GENE INDUCTION; GENE MUTATION; HYPOTHERMIA; INTESTINE EPITHELIUM; LIVER; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SENSITIVITY ANALYSIS;

EID: 84861822417     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI67477     Document Type: Erratum

References (57)

1. Berry MA, et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med. 2006;354(7):697-708. (Pubitemid 43247140)
2. Kollias G, Douni E, Kassiotis G, Kontoyiannis D. The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Ann Rheum Dis. 1999;58(suppl 1):I32-I39.
3. Wallis RS. Tumour necrosis factor antagonists: structure, function, and tuberculosis risks. Lancet Infect Dis. 2008;8(10):601-611.
4. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol. 2002;3(3):221-227.
5. Tracey KJ, et al. Shock and tissue injury induced by recombinant human cachectin. Science. 1986; 234(4775):470-474. (Pubitemid 17181429)
6. Bertini R, Bianchi M, Ghezzi P. Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J Exp Med. 1988; 167(5):1708-1712.
7. Libert C, Van Bladel S, Brouckaert P, Fiers W. The influence of modulating substances on tumor necrosis factor and interleukin-6 levels after injection of murine tumor necrosis factor or lipopolysaccharide in mice. J Immunother (1991). 1991;10(4):227-235.
8. Brouckaert P, Everaerdt B, Fiers W. The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor. Eur J Immunol. 1992;22(4):981-986.
9. Van Bogaert T, et al. TNF inhibits glucocorticoid receptor function in mice: A strong signal towards lethal shock. J Biol Chem. 2011;286(30):26555- 26567.
10. Jonat C, et al. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell. 1990; 62(6):1189-1204.
11. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS Jr. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol. 1995;15(2):943-953.
12. De Bosscher K. Selective Glucocorticoid Receptor modulators. J Steroid Biochem Mol Biol. 2010; 120(2-3):96-104.
13. Robertson S, et al. Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a. J Biol Chem. 2010;285(11):8061-8075.
14. Kassel O, Sancono A, Kratzschmar J, Kreft B, Stassen M, Cato AC. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 2001;20(24):7108-7116. (Pubitemid 34062302)
15. Clark AR. Anti-inflammatory functions of glucocorticoid-induced genes. Mol Cell Endocrinol. 2007;275(1-2):79-97. (Pubitemid 47259278)
16. Clark AR, Lasa M. Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways. Curr Opin Pharmacol. 2003;3(4):404-411. (Pubitemid 36908944)
17. Abraham SM, et al. Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1. J Exp Med. 2006; 203(8):1883-1889. (Pubitemid 44188463)
18. Hammer M, et al. Increased inflammation and lethality of Dusp1-/- mice in polymicrobial peritonitis models. Immunology. 2010;131(3):395-404.
19. Salojin KV, Owusu IB, Millerchip KA, Potter M, Platt KA, Oravecz T. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J Immunol. 2006;176(3):1899-907. (Pubitemid 43134335)
20. Heck S, et al. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 1994;13(17):4087-4095. (Pubitemid 24275865)
21. Reichardt HM, et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell. 1998;93(4):531-541. (Pubitemid 28240715)
22. Kleiman A, et al. Glucocorticoid receptor dimerization is required for survival in septic shock via suppression of interleukin-1 in macrophages. FASEB J. 2011;26(2):722-729.
23. Tuckermann JP, et al. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J Clin Invest. 2007;117(5):1381-1390. (Pubitemid 46718426)
24. Dietrich N, et al. JNK2 mediates TNF-induced cell death in mouse embryonic fibroblasts via regulation of both caspase and cathepsin protease pathways. Cell Death Differ. 2004;11(3):301-313. (Pubitemid 38313139)
25. Liedtke C, Trautwein C. The role of JNK2 in toxic liver injury. J Hepatol. 2006;45(5):762-764. (Pubitemid 44466671)
26. Fiers W, et al. TNF: its potential as an antitumour agent. Dev Biol Stand. 1988;69:143-151.
27. Brouckaert P, Libert C, Everaerdt B, Fiers W. Selective species specificity of tumor necrosis factor for toxicity in the mouse. Lymphokine Cytokine Res. 1992;11(4):193-196.
28. Yang D, Xie P, Guo S, Li H. Induction of MAPK phosphatase-1 by hypothermia inhibits TNF-alpha-induced endothelial barrier dysfunction and apoptosis. Cardiovasc Res. 2010;85(3):520-529.
29. Piguet PF, Vesin C, Guo J, Donati Y, Barazzone C. TNF-induced enterocyte apoptosis in mice is mediated by the TNF receptor 1 and does not require p53. Eur J Immunol. 1998;28(11):3499-3505. (Pubitemid 28510760)
30. Halpern MD, et al. Hepatic inflammatory mediators contribute to intestinal damage in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2003;284(4):G695-G702. (Pubitemid 36343219)
31. Karin M, Gallagher E. TNFR signaling: ubiquitin-conjugated TRAFfic signals control stop-andgo for MAPK signaling complexes. Immunol Rev. 2009;228(1):225-240.
32. Reichardt HM, et al. Repression of inflammatory responses in the absence of DNA binding by the gluco-corticoid receptor. EMBO J. 2001;20(24):7168-7173. (Pubitemid 34062308)
33. Valledor AF, Xaus J, Comalada M, Soler C, Celada A. Protein kinase C epsilon is required for the induction of mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J Immunol. 2000;164(1):29-37. (Pubitemid 30012968)
34. Kuwano Y, et al. MKP-1 mRNA stabilization and translational control by RNA-binding proteins HuR and NF90. Mol Cell Biol. 2008;28(14):4562-4575. (Pubitemid 351977754)
35. Reddy TE, et al. Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation. Genome Res. 2009; 19(12):2163-2171.
36. Shipp LE, et al. Transcriptional regulation of human dual specificity protein phosphatase 1 (DUSP1) gene by glucocorticoids. PloS One. 2010;5(10):e13754.
37. Frijters R, et al. Prednisolone-induced differential gene expression in mouse liver carrying wild type or a dimerization-defective glucocorticoid receptor. BMC Genomics. 2010;11:359.
38. Goldman G, Soffer D, Heller L, Aderka D, Lahat A, Klausner JM. Tumour necrosis factor mediates bacterial translocation after haemorrhagic shock and endotoxaemia. Eur J Surg. 2001;167(4):299-304. (Pubitemid 32336890)
39. McGuckin MA, Eri R, Simms LA, Florin TH, Radford-Smith G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis. 2009;15(1):100-113.
40. Wang X, Nelin LD, Kuhlman JR, Meng X, Welty SE, Liu Y. The role of MAP kinase phosphatase-1 in the protective mechanism of dexamethasone against endotoxemia. Life Sci. 2008;83(19-20):671-680.
41. Maier JV, et al. Dual specificity phosphatase 1 knockout mice show enhanced susceptibility to anaphylaxis but are sensitive to glucocorticoids. Mol Endocrinol. 2007;21(11):2663-2671. (Pubitemid 350035149)
42. Takahashi N, et al. IL-17 produced by Paneth cells drives TNF-induced shock. J Exp Med. 2008; 205(8):1755-1761.
43. Van Molle W, et al. HSP70 protects against TNF-induced lethal inflammatory shock. Immunity. 2002;16(5):685-695. (Pubitemid 34626689)
44. Nenci A, et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 2007;446(7135):557-561. (Pubitemid 46514732)
45. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell. 2005; 120(5):649-661. (Pubitemid 40343077)
46. Ventura JJ, Hubner A, Zhang C, Flavell RA, Shokat KM, Davis RJ. Chemical genetic analysis of the time course of signal transduction by JNK. Mol Cell. 2006;21(5):701-710. (Pubitemid 43290736)
47. Jin S, Ray RM, Johnson LR. Rac1 mediates intestinal epithelial cell apoptosis via JNK. Am J Physiol Gastrointest Liver Physiol. 2006;291(6):G1137- G1147. (Pubitemid 44904168)
48. Ray RM, Jin S, Bavaria MN, Johnson LR. Regulation of JNK activity in the apoptotic response of intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2011;300(5):G761-G770.
49. Bhattacharyya S, Brown DE, Brewer JA, Vogt SK, Muglia LJ. Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood. 2007;109(10):4313- 4319. (Pubitemid 46743398)
50. Song WB, et al. Curcumin protects intestinal mucosal barrier function of rat enteritis via activation of MKP-1 and attenuation of p38 and NF-kappaB activation. PloS One. 2010;5(9):e12969.
51. Bladh LG, Johansson-Haque K, Rafter I, Nilsson S, Okret S. Inhibition of extracellular signal-regulated kinase (ERK) signaling participates in repression of nuclear factor (NF)-kappaB activity by glucocorticoids. Biochim Biophys Acta. 2009;1793(3):439-446.
52. Onda K, Nagashima M, Kawakubo Y, Inoue S, Hirano T, Oka K. Mitogen-activated protein kinase kinase 1/extracellular signal-regulated kinase (MEK-1/ERK) inhibitors sensitize reduced glucocorticoid response mediated by TNFalpha in human epidermal keratinocytes (HaCaT). Biochem Biophys Res Commun. 2006;351(1):266-272. (Pubitemid 44635436)
53. Dorfman K, Carrasco D, Gruda M, Ryan C, Lira SA, Bravo R. Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene. 1996;13(5):925-931. (Pubitemid 26329078)
54. Van Snick J, et al. Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci U S A. 1986;83(24):9679-9683. (Pubitemid 17223420)
55. Vandesompele J, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):RESEARCH0034.
56. Tchen CR, Martins JR, Paktiawal N, Perelli R, Saklatvala J, Clark AR. Glucocorticoid regulation of mouse and human dual specificity phosphatase 1 (DUSP1) genes: unusual cis-acting elements and unexpected evolutionary divergence. J Biol Chem. 2009;285(4):2642-2652.
57. Bansal V, et al. Traumatic brain injury and intestinal dysfunction: uncovering the neuro-enteric axis. J Neurotrauma. 2009;26(8):1353-1359.